Findings

What do systematic reviews say?

1,017 questions · 1,061 findings · 131 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 193 · 18.2%GRADE not reported 65 · 6.1%Very low 237 · 22.3%Low 325 · 30.6%Moderate 187 · 17.6%High 54 · 5.1%

Perioperative infraorbital nerve block vs Intravenous analgesia

Need for analgesic prescription for pain (supplemental analgesic requirements) · Children up to 13 years of age, undergoing cleft lip repair surgery

It is very uncertain whether perioperative infraorbital nerve block changes need for analgesic prescription for pain (supplemental analgesic… compared with intravenous analgesia (very low certainty).

1 finding from 1 review

Infraorbital nerve block for postoperative pain following cleft lip repair in children 2016 · Cochrane All outcomes
RR 0.27 [0.13, 0.55]
1 study · 82 participants
Very low

Perioperative infraorbital nerve block vs Intravenous analgesia

Heart rate, respiratory rate, and blood pressure · Children up to 13 years of age, undergoing cleft lip repair surgery

The review found no eligible studies for this question.

1 finding from 1 review

Infraorbital nerve block for postoperative pain following cleft lip repair in children 2016 · Cochrane All outcomes
The included studies did not report these outcomes.
0 studies
No studies found

Subcutaneous insulin lispro vs intravenous regular insulin

All‐cause mortality (N) Mean hospital stay: 2‐7 days

1 finding from 1 review

Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 156 participants
Moderate

Subcutaneous insulin aspart vs intravenous regular insulin

Morbidity

The review found no eligible studies for this question.

1 finding from 1 review

Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Subcutaneous insulin aspart vs intravenous regular insulin

Adverse events other than hypoglycaemic episodes

The review found no eligible studies for this question.

1 finding from 1 review

Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Subcutaneous insulin aspart vs intravenous regular insulin

Time to resolution of diabetic ketoacidosis (h) Mean hospital stay: 3‐5 days

1 finding from 1 review

Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Very low

Subcutaneous insulin aspart vs intravenous regular insulin

Patient satisfaction

The review found no eligible studies for this question.

1 finding from 1 review

Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Subcutaneous insulin aspart vs intravenous regular insulin

Length of hospital stay

1 finding from 1 review

Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Low

Subcutaneous insulin lispro vs intravenous regular insulin

Hypoglycaemic episodes

Subcutaneous insulin lispro showed no clear difference in hypoglycaemic episodes (N) Mean hospital stay: 2‐7 days compared with intravenous regular insulin (low certainty).

1 finding from 1 review

Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
RR 0.59 [0.23, 1.52]
4 studies · 156 participants
Low

Subcutaneous insulin lispro vs intravenous regular insulin

Length of hospital stay

2 findings from 1 review

Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 96 participants
GRADE not reported
Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 90 participants
Low

Subcutaneous insulin lispro vs intravenous regular insulin

Adverse events other than hypoglycaemic episodes

The review found no eligible studies for this question.

1 finding from 1 review

Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Subcutaneous insulin lispro vs intravenous regular insulin

Time to resolution of diabetic ketoacidosis (h) Mean hospital stay: 2‐4 days

1 finding from 1 review

Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 90 participants
Very low

Subcutaneous insulin lispro vs intravenous regular insulin

Patient satisfaction

The review found no eligible studies for this question.

1 finding from 1 review

Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Subcutaneous insulin aspart vs intravenous regular insulin

All‐cause mortality (N) Mean hospital stay: 2‐7 days

1 finding from 1 review

Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 45 participants
Low

Subcutaneous insulin aspart vs intravenous regular insulin

Hypoglycaemic episodes

Subcutaneous insulin aspart showed no clear difference in hypoglycaemic episodes (N) Mean hospital stay: 3‐5 days compared with intravenous regular insulin (low certainty).

1 finding from 1 review

Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
RR 1 [0.07, 14.55]
1 study · 30 participants
Low

Perioperative infraorbital nerve block vs Intravenous analgesia

Duration of postoperative analgesia · Children up to 13 years of age, undergoing cleft lip repair surgery

The review found no eligible studies for this question.

1 finding from 1 review

Infraorbital nerve block for postoperative pain following cleft lip repair in children 2016 · Cochrane All outcomes
This outcome was not reported.
0 studies
No studies found

Perioperative infraorbital nerve block vs Intravenous analgesia

Analgesia durationTime duration from the end of surgery to the time of first analgesic consumption. Scale from: 0 to 100. · Children up to 13 years of age, undergoing cleft lip repair surgery

1 finding from 1 review

Infraorbital nerve block for postoperative pain following cleft lip repair in children 2016 · Cochrane All outcomes
Not pooled (lack of data). Delgado 2005: longer in the infraorbital block group (7.3 +/- 5.1 hours) versus intravenous analgesia (2.8 +/- 2.2 hours) (P < 0.01). Simion 2008: no significant difference (195.32 +/- 71.21…
3 studies
GRADE not reported

Primary analysis: less vs more frequent

Catheter‐related BSI as defined using criteria specified by Maki 2006; Mermel 2009; and O'Grady 2002 · patients with intravenous administration set replacement

Primary analysis: less showed no clear difference in catheter‐related BSI as defined using criteria specified by Maki… compared with more frequent (low certainty).

1 finding from 1 review

Optimal timing for intravascular administration set replacement 2013 · Cochrane Headline outcomes only
RR 1.06 [0.66, 1.68]
8 studies · 1794 participants
Low

Primary analysis: less vs more frequent

Infusate‐related BSI as defined using criteria specified by O'Grady 2002 · patients with intravenous administration set replacement

Primary analysis: less showed no clear difference in infusate‐related BSI as defined using criteria specified by O'Grady… compared with more frequent (low certainty).

1 finding from 1 review

Optimal timing for intravascular administration set replacement 2013 · Cochrane Headline outcomes only
RR 0.69 [0.31, 1.51]
11 studies · 1847 participants
Low

Primary analysis: less vs more frequent

Infusate colonization any positive quantitative culture of infusate · patients with intravenous administration set replacement

Primary analysis: less showed no clear difference in infusate colonization any positive quantitative culture of infusate compared with more frequent (low certainty).

1 finding from 1 review

Optimal timing for intravascular administration set replacement 2013 · Cochrane Headline outcomes only
RR 1.15 [0.7, 1.86]
8 studies · 1549 participants
Low